Selected article for: "cell activation and immune cell"
Author: Yu, Haijing; Liu, Yang; Wang, Hongwu; Wan, Xiaoyang; Huang, Jiaquan; Yan, Weiming; Xi, Dong; Luo, Xiaoping; Shen, Guanxin; Ning, Qin
Title: Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression
  • Document date: 2018_12_13
    • ID: 0ozhye9q_1
    Snippet: Fulminant hepatitis (FH) is a serious life-threatening disease characterized by massive hepatocyte necrosis, severe liver damage, and high mortality. The underlying mechanisms and the pathogenesis of FH are not clear. However, accumulating evidence suggests that, regardless of the pathogenesis of FH, the host's inflammatory responses contribute to liver microcirculatory disorders and injuries. Accordingly, It has been shown that immune cell activ.....
    Document: Fulminant hepatitis (FH) is a serious life-threatening disease characterized by massive hepatocyte necrosis, severe liver damage, and high mortality. The underlying mechanisms and the pathogenesis of FH are not clear. However, accumulating evidence suggests that, regardless of the pathogenesis of FH, the host's inflammatory responses contribute to liver microcirculatory disorders and injuries. Accordingly, It has been shown that immune cell activation and inflammatory cytokines play an important role in FH (1) . In recent years, our laboratory has conducted extensive research on the pathogenesis of FH and found that immune cells play a key role in it. Kupffer cells, natural killer (NK) cells (2, 3) , cytotoxic T-lymphocytes (CTLs), and double negative T-cells (DNT) (4) (5) (6) in liver and the cytokines that are produced by these cells cause liver damage.

    Search related documents:
    Co phrase search for related documents
    • cell activation and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • cell activation and host inflammatory response: 1, 2, 3, 4
    • cell activation and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell activation and immune cell activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell produce and high mortality: 1, 2, 3
    • cell produce and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • extensive research and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • extensive research and host inflammatory response: 1
    • extensive research and immune cell: 1, 2, 3, 4
    • FH Fulminant hepatitis and FH pathogenesis: 1, 2, 3
    • FH Fulminant hepatitis and Fulminant hepatitis: 1, 2, 3, 4, 5, 6, 7
    • FH Fulminant hepatitis and high mortality: 1
    • FH Fulminant hepatitis and immune cell: 1
    • FH pathogenesis and Fulminant hepatitis: 1, 2, 3, 4
    • FH pathogenesis and hepatocyte necrosis: 1
    • FH pathogenesis and immune cell: 1
    • Fulminant hepatitis and hepatocyte necrosis: 1, 2, 3
    • Fulminant hepatitis and high mortality: 1, 2, 3, 4, 5, 6
    • Fulminant hepatitis and immune cell: 1, 2